questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the voluntary scheme for branded medicines pricing and access on (a) development of and (b) access to (i) Graft-versus-Host diseas
answerText: The voluntary scheme for branded medicines pricing and access (VPAS) includes strong commercial incentives to launch new products in the form of freedom of list pricing and exemptions from payments for innovative medicines containing a new active substanc...
heading: Voluntary Scheme for Branded Medicines Pricing and Access